Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 010379
Company: KING PHARMS
Company: KING PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CYTOMEL | LIOTHYRONINE SODIUM | EQ 0.005MG BASE | TABLET;ORAL | Prescription | AB | Yes | No |
CYTOMEL | LIOTHYRONINE SODIUM | EQ 0.025MG BASE | TABLET;ORAL | Prescription | AB | Yes | No |
CYTOMEL | LIOTHYRONINE SODIUM | EQ 0.05MG BASE | TABLET;ORAL | Prescription | AB | Yes | No |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
12/21/2018 | SUPPL-54 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/010379s054lbl.pdf | |
05/17/2002 | SUPPL-47 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/10379s47lbl.pdf |